Butorphanol: Effects of a Prototypical Agonist-Antagonist Analgesic on κ-Opioid Receptors

The opioid analgesic, butorphanol (17-cyclobutylmethyl-3,14-dihydroxymorphinan) tartrate is a prototypical agonist-antagonist opioid analgesic agent whose potential for abuse has been the cause of litigation in the United States. With a published affinity for opioid receptors in vitro of 1:4:25 (µ:δ...

Full description

Bibliographic Details
Published in:	Journal of Pharmacological Sciences
Main Authors:	Stephen Commiskey, Lir-Wan Fan, Ing K. Ho, Rob W. Rockhold
Format:	Article
Language:	English
Published:	Elsevier 2005-01-01
Online Access:	http://www.sciencedirect.com/science/article/pii/S1347861319321899

Similar Items

Novel <i>N</i>-normetazocine Derivatives with Opioid Agonist/Sigma-1 Receptor Antagonist Profile as Potential Analgesics in Inflammatory Pain
by: Rita Turnaturi, et al.
Published: (2022-08-01)

Decoding the κ Opioid Receptor (KOR): Advancements in Structural Understanding and Implications for Opioid Analgesic Development
by: Zoe Li, et al.
Published: (2024-06-01)

Generalization of NMDA-Receptor Antagonists to the Discriminative Stimulus Effects of κ-Opioid Receptor Agonists U-50,488H, but Not TRK-820 in Rats
by: Tomohisa Mori, et al.
Published: (2006-01-01)

Repurposing of a Nucleoside Scaffold from Adenosine Receptor Agonists to Opioid Receptor Antagonists
by: Dilip K. Tosh, et al.
Published: (2018-10-01)

Nonspecific Effects of the Selective κ-Opioid Receptor AgonistU-50,488H on Dopamine Uptake and Release in PC12 Cells
by: Nuannoi Chudapongse, et al.
Published: (2003-01-01)

Pharmacologic Targets and Prototype Therapeutics in the Kallikrein-Kinin System: Bradykinin Receptor Agonists or Antagonists
by: J. N. Sharma, et al.
Published: (2006-01-01)

Docking 14 Million Virtual Isoquinuclidines against the μ and κ Opioid Receptors Reveals Dual Antagonists–Inverse Agonists with Reduced Withdrawal Effects
by: Seth F. Vigneron, et al.
Published: (2025-04-01)

<it>In vivo </it>antinociception of potent mu opioid agonist tetrapeptide analogues and comparison with a compact opioid agonist - neurokinin 1 receptor antagonist chimera
by: Guillemyn Karel, et al.
Published: (2012-01-01)

Muscarinic Receptor Agonists and Antagonists
by: David R. Kelly, et al.
Published: (2001-02-01)

Discovery of Novel Delta Opioid Receptor (DOR) Inverse Agonist and Irreversible (Non-Competitive) Antagonists
by: Parthasaradhireddy Tanguturi, et al.
Published: (2021-11-01)

Analgesic Effect of Butorphanol during Castration in Donkeys under Total Intravenous Anaesthesia
by: Paola Straticò, et al.
Published: (2021-08-01)

Selective κ opioid antagonists nor-BNI, GNTI and JDTic have low affinities for non-opioid receptors and transporters.
by: Thomas A Munro, et al.
Published: (2013-01-01)

The effect of opioid analgesics, benzodiazepines, gabapentinoids, and opioid agonist treatment on mortality risk among opioid-dependent people.
by: Chrianna Bharat, et al.
Published: (2022-08-01)

Mechanistic Characterization of the Pharmacological Profile of HS-731, a Peripherally Acting Opioid Analgesic, at the µ-, δ-, κ-Opioid and Nociceptin Receptors
by: Kristina Puls, et al.
Published: (2022-01-01)

Modification of κ-Opioid Receptor Agonist-Induced Antinociception by Diabetes in the Mouse Brain and Spinal Cord
by: Masahiro Ohsawa, et al.
Published: (2005-01-01)

Design of κ-Opioid Receptor Agonists for the Development of Potential Treatments of Pain with Reduced Side Effects
by: Federica Santino, et al.
Published: (2023-01-01)

Opioid analgesics for chronic noncancer pain in patients prescribed opioid agonist therapy or with opioid use disorder: A systematic review
by: Vahid Ashoorion, et al.
Published: (2025-12-01)

Dezocine Exerts Analgesic Effects in Chronic Pain by Activation of κ- and μ-Opioid Receptors and Inhibition of Norepinephrine and Serotonin Reuptake
by: Zihan Liu, et al.
Published: (2025-01-01)

Non-Peptide Agonists and Antagonists of the Prokineticin Receptors
by: Roberta Lattanzi, et al.
Published: (2022-12-01)

Agonists Specific for κ-Opioid Receptor Induces Apoptosis of HCC Cells Through Enhanced Endoplasmic Reticulum Stress
by: Mengyuan Tan, et al.
Published: (2022-03-01)

Design and development of novel, short, stable dynorphin-based opioid agonists for safer analgesic therapy
by: Rink-Jan Lohman, et al.
Published: (2023-03-01)

Effects of the novel selective κ-opioid receptor agonist NP-5497-KA on morphine-induced reward-related behaviors
by: Soichiro Ide, et al.
Published: (2023-10-01)

Erratum: Agonists Specific for κ-Opioid Receptor Induces Apoptosis of HCC Cells Through Enhanced Endoplasmic Reticulum Stress
by: Frontiers Production Office
Published: (2022-05-01)

Role for μ-opioid receptor in antidepressant effects of δ-opioid receptor agonist KNT-127
by: Yuki Moriya, et al.
Published: (2023-03-01)

Comparison of Postoperative Analgesic Effects of Medetomidine-Ketamine, Isoflurane and Medetomidine-Butorphanol, Isoflurane Combinations in Anesthesia for Ovariohysterectomy in Cats
by: Yalım UZEL, et al.
Published: (2025-06-01)

Structure-guided design of partial agonists at an opioid receptor
by: Balazs R. Varga, et al.
Published: (2025-03-01)

Butorphanol in Labour Analgesia
by: Jyotsna Yadav, et al.
Published: (2018-12-01)

Nalfurafine hydrochloride, a selective κ opioid receptor agonist, has no reinforcing effect on intravenous self-administration in rhesus monkeys
by: Xiulu Ruan
Published: (2016-09-01)

Nalfurafine hydrochloride, a selective κ opioid receptor agonist, has no reinforcing effect on intravenous self-administration in rhesus monkeys
by: Kaoru Nakao, et al.
Published: (2016-01-01)

IUPHAR Review - Bivalent and bifunctional opioid receptor ligands as novel analgesics
by: Kyle J. Rehrauer, et al.
Published: (2023-11-01)

Agonists, Antagonists and Receptors of Somatostatin: Pathophysiological and Therapeutical Implications in Neoplasias
by: Argyrios Periferakis, et al.
Published: (2024-09-01)

Small Molecule Follicle-Stimulating Hormone Receptor Agonists and Antagonists
by: Ross C. Anderson, et al.
Published: (2019-01-01)

Agonist and antagonist TRUPATH assays for G protein-coupled receptors
by: Jeffrey F. DiBerto, et al.
Published: (2022-06-01)

Long-term agonist and antagonist therapy for adolescent opioid dependence: A description of two cases
by: Rajeev Ranjan, et al.
Published: (2014-01-01)

Xylazine is an agonist at kappa opioid receptors and exhibits sex-specific responses to opioid antagonism
by: Madigan L. Bedard, et al.
Published: (2024-06-01)

Differential interaction patterns of opioid analgesics with µ opioid receptors correlate with ligand-specific voltage sensitivity
by: Sina B Kirchhofer, et al.
Published: (2023-11-01)

Effect of Butorphanol-Medetomidine and Butorphanol-Dexmedetomidine on Echocardiographic Parameters during Propofol Anaesthesia in Dogs
by: Andrej Bočkay, et al.
Published: (2024-05-01)

Opioid analgesics: Managing the predictable
by: A Barnes, et al.
Published: (2025-07-01)

Non-opioid analgesic options
by: T. G.A. Leonard
Published: (2018-08-01)

Dynamics of agonist-evoked opioid receptor activation revealed by FRET- and BRET-based opioid receptor conformation sensors
by: Sina B. Kirchhofer, et al.
Published: (2025-02-01)